Avery W. Catlin
2013
In 2013, Avery W. Catlin earned a total compensation of $1.4M as Senior Vice President and Chief Financial Officer at Celldex Therapeutics, a 95% increase compared to previous year.
Compensation breakdown
| Bonus | $130,000 |
|---|---|
| Option Awards | $945,090 |
| Salary | $307,735 |
| Other | $5,767 |
| Total | $1,388,592 |
Catlin received $945.1K in option awards, accounting for 68% of the total pay in 2013.
Catlin also received $130K in bonus, $307.7K in salary and $5.8K in other compensation.
Rankings
In 2013, Avery W. Catlin's compensation ranked 5,244th out of 12,286 executives tracked by ExecPay. In other words, Catlin earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,244 out of 12,286 | 57th |
Division Manufacturing | 1,812 out of 4,612 | 61st |
Major group Chemicals And Allied Products | 520 out of 1,462 | 64th |
Industry group Drugs | 370 out of 1,156 | 68th |
Industry In Vitro and In Vivo Diagnostic Substances | 18 out of 56 | 68th |
Source: SEC filing on April 21, 2016.
Catlin's colleagues
We found four more compensation records of executives who worked with Avery W. Catlin at Celldex Therapeutics in 2013.